Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check54 days agoChange DetectedThe website has been updated to version v2.10.0, adding two new interventions/treatments and indicating that the study now has one location.SummaryDifference0.7%
- Check61 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check75 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check78 days agoChange DetectedThe value 'No Results Posted' has recently changed to 'Results Submitted', indicating that the study results have been submitted for this particular clinical trial on the webpage.SummaryDifference0.2%
Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.